Global Inhaled Nitric Oxide Market 2024-2028
Global Inhaled Nitric Oxide Market 2024-2028
The inhaled nitric oxide market is forecasted to grow by USD 462.5 mn during 2023-2028, accelerating at a CAGR of 10.77% during the forecast period. The report on the inhaled nitric oxide market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by use of inhaled nitric oxide in cardiac surgeries, increasing organic strategic initiatives, and rise in research and development activities.
Technavio's inhaled nitric oxide market is segmented as below:
- By Application
- Neonatal respiratory treatment
- Chronic obstructive pulmonary disease (COPD)
- Acute respiratory distress syndrome (ARDS)
- Others
- By Geographical Landscape
- North America
- APAC
- Europe
- South America
- Middle East and Africa
This study identifies the rise in the number of patients with copd as one of the prime reasons driving the inhaled nitric oxide market growth during the next few years. Also, increase in the prevalence of diseases in the newborn and fda encouragement for clinical inhaled nitric oxide will lead to sizable demand in the market.
The report on the inhaled nitric oxide market covers the following areas:
- Inhaled nitric oxide market sizing
- Inhaled nitric oxide market forecast
- Inhaled nitric oxide market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading inhaled nitric oxide market vendors that include Air Liquide SA, Berkeley Life and L2G North America Inc., Beyond Air Inc, Geno Pharmaceuticals Pvt. Ltd., Getinge AB, Halma Plc, HumanN, Inspiration Healthcare Group Plc., Linde Plc, Mallinckrodt Plc, Merck KGaA, Moda Health Plan Inc., NIOX Group plc, SOL India Pvt Ltd, The Cigna Group, Uniscience Group, and VERO Biotech. Also, the inhaled nitric oxide market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.